SCHEMBL564492

SCHEMBL564492

CC(C)=CCc1c(O)c(CC=C(C)C)c2c(c1O)C(=O)[C@H](O)[C@@H](c1ccc(O)cc1O)O2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.67
▸ MAPT P10636 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ XBP1 P17861 1/20 0.52
▸ ABCG2 Q9UNQ0 2/20 0.49
▸ CYP19A1 P11511 1/20 0.49
▸ GABRA1 P14867 1/20 0.47
▸ GABRB2 P47870 1/20 0.47
▸ CACNA1H O95180 3/20 0.46
▸ ESR1 P03372 3/20 0.44
▸ ESR2 Q92731 2/20 0.44
▸ MAOA P21397 2/20 0.44
▸ CACNA1G O43497 2/20 0.44
▸ AKR1B10 O60218 1/20 0.44
▸ AKR1B1 P15121 1/20 0.44
▸ PDE5A O76074 1/20 0.44
▸ PTPN1 P18031 2/20 0.43
▸ MGAM O43451 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27013445 0.87 BACE1 (0.58) IDO1MAPTKMT2AMEN1POLB
SCHEMBL17626616 0.80 IDO1 (1.00) IDO1MAPTKMT2AMEN1POLB
SCHEMBL564110 0.80 IDO1 (1.00) IDO1MAPTKMT2AMEN1POLB
SCHEMBL564482 0.79 BACE1 (0.57) IDO1ABCG2CYP19A1CACNA1HESR1
SCHEMBL4231030 0.77 CACNA1H (0.46) IDO1ABCG2CYP19A1CACNA1HESR1
Neophellamuretin SCHEMBL30766255 0.75 ABCG2 (0.66) MAPTKMT2AMEN1POLBXBP1
Neophellamuretin SCHEMBL27013455 0.75 ABCG2 (0.66) MAPTKMT2AMEN1POLBXBP1
Kushenol X SCHEMBL4809925 0.75 BACE1 (0.72) IDO1ABCG2CYP19A1CACNA1HESR1
SCHEMBL22922168 0.72 GABRA1 (0.66) MAPTKMT2AABCG2GABRA1GABRB2
SCHEMBL30634928 0.72 GABRA1 (0.66) MAPTKMT2AABCG2GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101507750-B Use of kuhseng total-flavone in preparing medicine UNIV DALIAN MEDICAL 2012-10-03 — — CN claimed
CN-1348762-A Application of kusheng (sophora Flavescences) flavone in preparing hypoglycemic LUZHOU BAOGUANG PHARMACEUTICAL (CN) 2002-05-15 — — CN claimed
CN-118501283-A Quick fishing method for traditional Chinese medicine active components based on multi-target proteins 云南中医药大学 2024-08-16 — — CN disclosed
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS BETH ISRAEL DEACONESS MEDICAL CENTER, INC. 2024-01-18 — — US disclosed
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS BETH ISRAEL DEACONESS MEDICAL CENTER, INC. 2024-01-18 — — US disclosed
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS BETH ISRAEL DEACONESS MEDICAL CENTER, INC. 2024-01-18 — — US disclosed
CN-117074547-A Method for analyzing fertility of sand road in spring 广东省药品检验所(广东省药品质量研究所、广东省口岸药品检验所) 2023-11-17 — — CN disclosed
US-10744219-B2 Air freshener composition and preparation method thereof Guorun Biotechnology (Shenzhen) Co., Ltd. (CN) 2020-08-18 — — US disclosed
US-20200164096-A1 AIR FRESHENER COMPOSITION AND PREPARATION METHOD THEREOF Guorun Biotechnology (Shenzhen) Co., Ltd. (CN) 2020-05-28 — — US disclosed
EP-3388137-B1 AIR FRESHENER COMPOSITION AND PREPARATION METHOD THEREFOR WANG JINGNING (CN) 2020-04-15 — — EP disclosed
EP-3388137-A1 AIR FRESHENER COMPOSITION AND PREPARATION METHOD THEREFOR Wang, Jingning (CN) 2018-10-17 — — EP disclosed
CN-101507750-B Use of kuhseng total-flavone in preparing medicine UNIV DALIAN MEDICAL 2012-10-03 — — CN disclosed
CN-102030812-B Timosaponin A-III serving as medicinal active ingredient with angiogenesis resistance UNIV TSINGHUA 2012-07-04 — — CN disclosed
US-20120035855-A1 METHOD OF NETWORK-BASED IDENTIFICATION FOR DRUG ACTION AND/OR SYNERGY EFFECT OF MEDICINE COMBINATION TSINGHUA UNIVERSITY 2012-02-09 — — US disclosed
EP-2369493-A1 GENE NETWORK-BASED METHOD FOR CONFIRMING DRUG ACTION Tsinghua University (CN) 2011-09-28 — — EP disclosed
WO-2010066150-A9 GENE NETWORK-BASED METHOD FOR CONFIRMING DRUG ACTION 清华大学 (CN) 2011-07-21 — — WO disclosed
CN-102030812-A Timosaponin A-III serving as medicinal active ingredient with angiogenesis resistance UNIV TSINGHUA 2011-04-27 — — CN disclosed
CN-102028679-A Vitexin as active ingredient of medicine with anti-angiogenesis effect UNIV TSINGHUA 2011-04-27 — — CN disclosed
CN-101507750-A Use of kuhseng total-flavone in preparing medicine UNIV DALIAN MEDICAL (CN) 2009-08-19 — — CN disclosed
CN-1348762-A Application of kusheng (sophora Flavescences) flavone in preparing hypoglycemic LUZHOU BAOGUANG PHARMACEUTICAL (CN) 2002-05-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS THPO, SERPINB1, SERPINC1 IDO1 3111/4885MAPT 2717/4885KMT2A 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback